Two New Reports on The Pharmacy Benefit Just Released

Comprehensive Report Examines the Pharmacy Benefit From Three Key Perspectives

The 2010-2011 edition of The Boehringer Ingelheim Pharmacy Benefits Report reveals the experiences and expectations of employers, health plans, and pharmacy benefit managers/specialty pharmacy providers in designing and managing the pharmacy benefit. Research findings are analyzed and interpreted by industry experts. You can use the national data detailed in the report to benchmark your organization's policies and outcomes.

Among the report findings:

• Medical costs are outpacing pharmacy costs
• Diabetes and cancer are top cost concerns
  
• Employers see clear link between employee health and productivity
  
• Health plans are already using evidence-based research findings to alter formularies
  
• Medication adherence is seen as key to improving health outcomes.

For your free copy of the complete report, click here.

Companion Report Focuses on Medicare Part D and the Medical Home

The 2010-2011 edition of The Boehringer Ingelheim Medicare Part D & Patient-Centered Medical Home Report examines the experiences and opinions of health plans in marketing to Medicare Part D beneficiaries and the extent to which health plans are embracing the medical home concept. Survey findings are analyzed by industry experts and supported by other research.

Among the report findings:

• Part D plans are aggressively marketing to younger and healthier patient populations.
• The top 5 therapeutic categories in drug spend are: diabetes, hyperlipidemia, hypertension, cancer, and depression.
• Nearly one-third of Part D plan members reached the donut hole coverage gap in 2009.
• Part D plans agree that widespread adoption of health information technology will improve patient outcomes.
• Almost two-thirds of Part D plans support the medical home concept.